(Q38479141)

3 September 2017

FISH detection of HER-2/neu oncogene amplification in early onset breast cancer (English)

1 reference

3 September 2017

W R Xing

1

1 reference

3 September 2017

K W Gilchrist

2

1 reference

3 September 2017

C P Harris

3

1 reference

3 September 2017

W Samson

4

1 reference

3 September 2017

L F Meisner

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

Breast Cancer Research and Treatment

3 September 2017

1 reference

3 September 2017

39

1 reference

3 September 2017

203-212

1 reference

3 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01806187

3 September 2017

0 references

cites work

Improved quantitation of HER-2/neu gene copy number in breast tumor-derived DNA samples

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01806187

Cell biological factors associated with the response of breast cancer to systemic treatment

21 January 2018

1 reference

12 December 2020

Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?

1 reference

12 December 2020

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

12 December 2020

Age as prognostic factor in premenopausal breast carcinoma

1 reference

12 December 2020

Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques

1 reference

12 December 2020

Detection of aneuploidy and possible deletion in paraffin-embedded rhabdomyosarcoma cells with FISH.

1 reference

12 December 2020

Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer

1 reference

12 December 2020

High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group).

1 reference

12 December 2020

DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer

1 reference

12 December 2020

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

1 reference

12 December 2020

Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer

1 reference

12 December 2020

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

1 reference

12 December 2020

c-erbB-2 andras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome

1 reference

12 December 2020

Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy

1 reference

12 December 2020

Genetic markers as prognostic indicators in breast cancer

1 reference

12 December 2020

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

1 reference

12 December 2020

Prognostic factors in early breast carcinoma.

1 reference

12 December 2020

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

1 reference

12 December 2020

Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type

1 reference

12 December 2020

Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).

1 reference

12 December 2020

Inherited susceptibility to breast cancer

1 reference

12 December 2020

Human breast cancer: correlation study between HER-2/neu amplification and prognostic factors in an unselected population

1 reference

12 December 2020

Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer

1 reference

12 December 2020

Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment

1 reference

12 December 2020

Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma

1 reference

12 December 2020

The p53 tumor suppressor gene in breast cancer

1 reference

12 December 2020

Prognosis and treatment decisions in patients with breast cancer without axillary node involvement

1 reference

12 December 2020

Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas

1 reference

12 December 2020

Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions

1 reference

12 December 2020

Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

Breast cancer outcome and predictors of outcome: are there age differentials?

1 reference

12 December 2020

Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients

1 reference

12 December 2020

Trends in breast cancer in younger women in contrast to older women

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01806187

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference